MTOR and obesity disorder: Many of these effects of obesity operate through the PI3K/ATK/mTOR (e.g., insulin) or LkB-AMPK/mTOR (e.g., adiponectin) pathways [26], such that obesity affects pathways which may, in turn, support FFM retention.